Evolent Health Inc [NYSE: EVH] gained 0.86% or 2589988.37 points to close at $2590000.0 with a heavy trading volume of 4332012 shares.
It opened the trading session at $11.21, the shares rose to $11.73 and dropped to $10.89, the range by which the price of stock traded the whole day. The daily chart for EVH points out that the company has recorded 5.39% gains over the past six months.
If we look at the average trading volume of 2.59M shares, EVH reached to a volume of 4332012 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Evolent Health Inc [EVH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVH shares is $15.08 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVH stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Evolent Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on January 10, 2025. While these analysts kept the previous recommendation, BTIG Research dropped their target price from $36 to $29. The new note on the price target was released on December 03, 2024, representing the official price target for Evolent Health Inc stock. Previously, the target price had yet another drop from $38 to $16, while Stephens kept a Equal-Weight rating on EVH stock.
The Price to Book ratio for the last quarter was 1.45, with the Price to Cash per share for the same quarter was set at 2.24.
Trading performance analysis for EVH stock
Evolent Health Inc [EVH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.52. With this latest performance, EVH shares gained by 54.95% in over the last four-week period, additionally plugging by 5.39% over the last 6 months – not to mention a rise of 4.27% in the past year of trading.
Evolent Health Inc [EVH]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Evolent Health Inc [EVH] shares currently have an operating margin of -0.07% and a Gross Margin at 10.52%. Evolent Health Inc’s Net Margin is presently recorded at -5.86%.
Return on Equity for this stock declined to -4.11%, with Return on Assets sitting at -4.11%.
Evolent Health Inc [EVH]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EVH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolent Health Inc go to 25.00%.
An analysis of Institutional ownership at Evolent Health Inc [EVH]
There are presently around $109.46%, or 111.03%% of EVH stock, in the hands of institutional investors. The top three institutional holders of EVH stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 11.17 million shares, which is approximately 9.7383%. VANGUARD GROUP INC, holding 11.06 million shares of the stock with an approximate value of $$211.39 million in EVH stocks shares; and VANGUARD GROUP INC, currently with $$166.1 million in EVH stock with ownership which is approximately 7.5745%.
